Bavaria Corporation – Trademark Portfolio
Entity Type: 03
Bavaria Corporation holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include GOL, BAFOS, PROTECTA, and PREZERVIT. The owner is based in Apopka, FL.
515 Cooper Commerce Drive Suite 100
Apopka, FL 32703
Showing of trademarks Trademarks
Trademark Classifications
Bavaria Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Bavaria Corporation have?
Bavaria Corporation has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 1 abandoned, 1 cancelled.
What trademark classes does Bavaria Corporation file in?
Bavaria Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Bavaria Corporation's most well-known trademarks?
Bavaria Corporation's registered trademark portfolio includes well-known marks such as GOL, BAFOS, PROTECTA, and PREZERVIT. These are among 4 currently registered trademarks in the portfolio.
What is Bavaria Corporation's trademark registration success rate?
Bavaria Corporation has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.